News

Bandaram Pharma Packtech Limited (Scrip Code: 524602) will close its trading window from October 1, 2026, until 48 hours after the declaration of standalone and consolidated unaudited financial results for the quarter and half-year ended September 30, 2026, for designated persons, their immediate relatives, and connected persons, as per SEBI (Prohibition of Insider Trading) Regulations, 2015; the company will schedule a board meeting to consider and approve the results, and a separate notice will be sent to the BSE Limited.

Bandaram Pharma Packtech will hold a meeting of the Board of Directors of the Company on 13 August 2026.

Net profit of Bandaram Pharma Packtech declined 40.00% to Rs 0.09 crore in the quarter ended March 2026 as against Rs 0.15 crore during the previous quarter ended March 2025. Sales rose 209.31% to Rs 26.26 crore in the quarter ended March 2026 as against Rs 8.49 crore during the previous quarter ended March 2025.For the full year,net profit declined 18.18% to Rs 0.45 crore in the year ended March 2026 as against Rs 0.55 crore during the previous year ended March 2025. Sales rose 70.24% to Rs 62.92 crore in the year ended March 2026 as against Rs 36.96 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales26.268.49 209 62.9236.96 70 OPM %3.086.36 -4.617.66 - PBDT0.370.73 -49 1.412.30 -39 PBT0.120.20 -40 0.441.32 -67 NP0.090.15 -40 0.450.55 -18 Powered by Capital Market - Live News

Bandaram Pharma Packtech will hold a meeting of the Board of Directors of the Company on 30 May 2026.

Bandaram Pharma Packtech announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 27 April 2026.